Cardiac mechanoenergetics for understanding isoproterenol-induced rat heart failure

Pathophysiology

Volumn 19, Issue 3, 2012, Pages 163-170

  Takaki, Miyako ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Basal metabolism; ESPVR and EDPVR; Isoproterenol induced hypertrophy model; Mechanoenergetics; PVA independent VO 2 eEmax relation; SERCA2a; VO 2 PVA relation

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM ION; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DOBUTAMINE; ENZYME INHIBITOR; HISTONE ACETYLTRANSFERASE INHIBITOR; ISOPRENALINE; OXYGEN; PHOSPHOLAMBAN; PHOSPHOLEMMAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SERINE; SODIUM PROTON EXCHANGE PROTEIN 1 INHIBITOR; THAPSIGARGIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL METABOLIC RATE; BLOOD PRESSURE; CARDIAC MECHANOENERGETICS; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; HEART CONTRACTION; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE RELAXATION; HEART RATE; MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SARCOPLASMIC RETICULUM;

EID: 84865429624     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2012.04.004     Document Type: Article

References (43)

1. Boluyt M.O., Long X., Eschenhagen T., Mende U., Schmitz W., Crow M.T., Lakatta E.G. Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. American Journal of Physiology - Heart and Circulatory Physiology 1995, 269:H638-H647.
2. Stanton H.C., Brenner G., Mayfield E.D. Studies on isoproterenol-induced cardiomegaly in rats. American Heart Journal 1969, 77:72-80.
3. Zierhut W., Zimmer H.G. Significance of myocardial alpha- and beta-adrenoceptors in catecholamine-induced cardiac hypertrophy. Circulation Research 1989, 65:1417-1425.
4. Zhang G.-X., Kimura S., Nishiyama A., Shokoji T., Rahmana M., Yao L., Nagai Y., Fujisawa Y., Miyatake A., Abe Y. Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovascular Research 2005, 65:230-238.
5. Zhang G.-X., Ohmori K., Nagai Y., Fujisawa Y., Nishiyama A., Abe Y., Kimura S. Role of AT1 receptor in isoproternol-induced cardiac hypertrophy and oxidative stress in mice. Journal of Molecular and Cellular Cardiology 2007, 42:804-811.
6. Kitagawa Y., Tamura Y., Shimizu J., Nakajima-Takenaka C., Taniguchi S., Uesato S., Takaki M. Effects of novel histone deacetylase inhibitor, N-(2-amino-phenyl) benzamide on a reversible hypertrophy induced by isoproterenol in in situ rat hearts. Journal of Pharmacological Sciences 2007, 104:167-175.
7. Antos C.L., Frey N., Marx S.O., Reiken S., Gaburjakova M., Richardson J.A., Marks A.R., Olson E.N. Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase A. Circulation Research 2001, 89:938-940.
8. Leenen F.H., White R., Yuan B. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system. American Journal of Physiology - Heart and Circulatory Physiology 2001, 281:H2410-H2416.
9. Morisco C., Zebrowski D.C., Vatner D.E., Vatner S.F., Sadoshima J. Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart. Journal of Molecular and Cellular Cardiology 2001, 33:561-573.
10. Nagano M., Higaki J., Nakamura F., Higashimori K., Nagano N., Mikami H., Ogihara T. Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy. Hypertension 1992, 19:708-712.
11. Sugden P.H. Signaling in myocardial hypertrophy: life after calcineurin?. Circulation Research 1999, 84:633-646.
12. Sussman M.A., Lim H.W., Gude N., Taigen T., Olson E.N., Robbins J., Colbert M.C., Gualberto A., Wieczorek D.F., Molkentin J.D. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 1998, 281:1690-1693.
13. Saadane N., Apert L., Chalifour L.E. Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice. British Journal of Pharmacology 1999, 127:1165-1176.
14. Shibata M., Takeshita D., Obata K., Mitsuyama S., Ito H., Zhang G.-X., Takaki M. NHE-1 participates in isoproterenol-induced downregulation of SERCA2a and development of cardiac remodeling in rat hearts. American Journal of Physiology - Heart and Circulatory Physiology 2011, 301:H2154-H2160.
15. Kitagawa Y., Yamashita D., Ito H., Takaki M. The reversible effects of isoproterenol-induced hypertrophy on in situ left ventricular function in rat hearts. American Journal of Physiology - Heart and Circulatory Physiology 2004, 287:H277-H285.
16. Nakajima-Takenaka C., Zhang G.-X., Obata K., Tohne K., Matsuyoshi H., Nagai Y., Nishiyama A., Takaki M. Left ventricular function of isoproterenol-induced hypertrophied rat hearts perfused with blood: mechanical work and energetics. American Journal of Physiology - Heart and Circulatory Physiology 2009, 297:1736-1743.
17. Takeshita D., Shimizu J., Kitagawa Y., Yamashita D., Tohne K., Nakajima-Takenaka C., Ito H., Takaki M. Isoproterenol-induced hypertrophied rat hearts: does short-term treatment correspond to long-term treatment?. The Journal of Physiological Sciences 2008, 58:179-188.
18. 2 use-pressure-volume area relation from curved end-systolic pressure-volume relation of the blood-perfused rat left ventricle. Japanese Journal of Physiology 1998, 48:197-204.
19. Kishi T., Nakahashi K., Ito H., Taniguchi S., Takaki M. Effects of milrinone on left ventricular end-systolic pressure-volume relationship of rat hearts in situ. Clinical and Experimental Pharmacology and Physiology 2001, 28:737-742.
20. Lee S., Ohga Y., Tachibana H., Syuu Y., Ito H., Harada M., Suga H., Takaki M. Effects of myosin isozyme shift on curvilinearity of the left ventricular end-systolic pressure-volume relation of in situ rat hearts. Japanese Journal of Physiology 1998, 48:445-455.
21. Tachibana H., Takaki M., Lee S., Ito H., Yamaguchi H., Suga H. New mechano-energetic evaluation of left ventricular contractility in in situ rat hearts. American Journal of Physiology - Heart and Circulatory Physiology 1997, 272:H2671-H2678.
22. Georgakopoulos D., Kass D.A. Minimal force-frequency modulation of inotropy and relaxation of in situ murine heart. The Journal of Physiology (London) 2001, 534:535-545.
23. Kameyama T., Chen Z., Bell S.P., Fabian J., LeWinter M.M. Mechanoenergetic studies in isolated mouse hearts. American Journal of Physiology - Heart and Circulatory Physiology 1998, 274:H366-H374.
24. Takaki M. Left ventricular mechanoenergetics in small animals. Japanese Journal of Physiology 2004, 54:175-207.
25. Yoshikawa Y., Zhang G.-X., Obata K., Ohga Y., Matsuyoshi H., Taniguchi S., Takaki M. Cardioprotective effects of a novel calpain inhibitor SNJ-1945 for reperfusion injury after cardioplegic cardiac arrest. American Journal of Physiology - Heart and Circulatory Physiology 2010, 298:H643-H651.
26. Tsuji T., Ohga Y., Yoshikawa Y., Sakata S., Kohzuki H., Misawa H., Abe T., Tabayashi N., Kobayashi S., Kitamura S., Taniguchi S., Suga H., Takaki M. New index for oxygen cost of contractility from curved end-systolic pressure-volume relations in cross-circulated rat hearts. Japanese Journal of Physiology 1999, 49:513-520.
27. Takaki M., Matsubara H., Araki J., Zhao L.Y., Ito H., Yasuhara S., Fujii W., Suga H. Mechanoenergetics of acute failing hearts characterized by oxygen costs of mechanical energy and contractility. New Horizons for Failing Heart Syndrome 1996, 133-164. Springer-Verlag, Tokyo, Japan. S. Sasayama (Ed.).
28. 2 consumption and pressure-volume area in dog hearts. American Journal of Physiology - Heart and Circulatory Physiology 1987, 252:H1258-H1264.
29. Goto Y., Slinker B.K., Lewinter M.M. Similar normalized Emax and oxygen consumption-pressure-volume area relation in rabbit and dog hearts. American Journal of Physiology - Heart and Circulatory Physiology 1988, 255:H366-H374.
30. 2+-ATPase by cyclopiazonic acid in rat left ventricles. Japanese Journal of Physiology 2001, 51:99-108.
31. 2 consumption in isolated rabbit heart. American Journal of Physiology - Heart and Circulatory Physiology 1994, 266:H1047-H1054.
32. 2+ exchange inhibition protects the rat heart from ischemic-reperfusion injury by blocking energy-wasting processes. American Journal of Physiology - Heart and Circulatory Physiology 2005, 288:H1699-H1707.
33. 2+ overload: Possible link to the proteolysis of fodrin. American Journal of Physiology - Heart and Circulatory Physiology 2001, 281:H1286-H1294.
34. 2 of mechanically unloaded contraction of rat ventricular slices measured by a new approach. American Journal of Physiology 1996, 270:H1063-H1070.
35. 2+ overload-induced failing hearts. Japanese Journal of Physiology 2002, 52:163-171.
36. 2+ content and contraction in single myocytes of guinea-pig heart. Journal of Molecular and Cellular Cardiology 1993, 25:229-233.
37. 2+ content and contractions of single myocytes of rat ventricular myocardium. Journal of Physiology and Pharmacology 1993, 44:243-250.
38. 2+ transient in rat ventricular myocytes. Journal of Physiology 1993, 68:35-52.
39. 2 use of the excised blood-perfused rat heart. Journal of Molecular and Cellular Cardiology 1998, 30:2137-2143.
40. Suga H. Ventricular energetics. Physiological Reviews 1990, 70:247-277.
41. Opie L.H. Receptors and signal transduction. The Heart, Physiology, From Cell to Circulation 1998, Lippincott-Raven Press, Philadelphia, New York, pp. 173-207 (Chapter 7).
42. 2 use of unloaded contracting rat heart slices: thapigargin and cyclopiazonic acid. Journal of Molecular and Cellular Cardiology 1998, 30:649-659.
43. +-ATPase. American Journal of Physiology - Heart and Circulatory Physiology 2008, 295:H1615-H1625.